ONTOLOGY REPORT - ANNOTATIONS |
|
Term: | glycochenodeoxycholic acid |
|
Accession: | CHEBI:36274
|
browse the term
|
Definition: | A bile acid glycine conjugate having 3alpha,7alpha-dihydroxy-5beta-cholan-24-oyl as the bile acid component. |
Synonyms: | exact_synonym: | N-(3alpha,7alpha-dihydroxy-5beta-cholan-24-oyl)glycine; [(3alpha,7alpha-dihydroxy-24-oxo-5beta-cholan-24-yl)amino]acetic acid |
| related_synonym: | Chenodeoxyglycocholate; Formula=C26H43NO5; GCDCA; Glycochenodeoxycholate; InChI=1S/C26H43NO5/c1-15(4-7-22(30)27-14-23(31)32)18-5-6-19-24-20(9-11-26(18,19)3)25(2)10-8-17(28)12-16(25)13-21(24)29/h15-21,24,28-29H,4-14H2,1-3H3,(H,27,30)(H,31,32)/t15-,16+,17-,18-,19+,20+,21-,24+,25+,26-/m1/s1; InChIKey=GHCZAUBVMUEKKP-GYPHWSFCSA-N; SMILES=[H][C@@]12C[C@H](O)CC[C@]1(C)[C@@]1([H])CC[C@]3(C)[C@]([H])(CC[C@@]3([H])[C@]1([H])[C@H](O)C2)[C@H](C)CCC(=O)NCC(O)=O; chenodeoxycholylglycine; chenodeoxyglycocholic acid; glycine chenodeoxycholate |
| alt_id: | CHEBI:3591; CHEBI:41520; CHEBI:5463 |
| xref: | Beilstein:3226177 "Beilstein"; CAS:640-79-9 "ChemIDplus"; CAS:640-79-9 "KEGG COMPOUND"; DrugBank:DB02123; HMDB:HMDB0006898; KEGG:C05466 |
| xref_mesh: | MESH:D005999 |
| xref: | MetaCyc:GLYCOCHENODEOXYCHOLIC_ACID; PDBeChem:CHO; PMID:22770225 "Europe PMC"; PMID:23078175 "Europe PMC"; Reaxys:3226177 "Reaxys"; Wikipedia:Glycochenodeoxycholic_acid |
| cyclic_relationship: | is_conjugate_acid_of CHEBI:36252 |
|
|
|
G |
Agt |
angiotensinogen |
|
19 |
57,321,594 |
57,333,460 |
RGD:6480464 |
G |
Agtr1a |
angiotensin II receptor, type 1a |
|
17 |
35,907,102 |
35,958,136 |
RGD:6480464 |
G |
Bcl2a1 |
BCL2-related protein A1 |
|
8 |
96,551,424 |
96,559,527 |
RGD:6480464 |
G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
10 |
106,856,097 |
106,864,419 |
RGD:6480464 |
G |
Casp3 |
caspase 3 |
|
16 |
48,845,011 |
48,863,249 |
RGD:6480464 |
G |
Casp8 |
caspase 8 |
|
9 |
65,614,142 |
65,662,624 |
RGD:6480464 |
G |
Casp9 |
caspase 9 |
|
5 |
160,356,211 |
160,373,774 |
RGD:6480464 |
G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
|
9 |
65,534,608 |
65,586,395 |
RGD:6480464 |
G |
Cycs |
cytochrome c, somatic |
|
4 |
80,331,226 |
80,333,326 |
RGD:6480464 |
G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
7 |
70,578,564 |
70,585,074 |
RGD:6480464 |
G |
Gsta1 |
glutathione S-transferase alpha 1 |
|
9 |
27,366,404 |
27,381,004 |
RGD:6480464 |
G |
Gsta2 |
glutathione S-transferase alpha 2 |
|
8 |
85,640,081 |
85,645,621 |
RGD:6480464 |
G |
Hgf |
hepatocyte growth factor |
|
4 |
15,435,460 |
15,505,377 |
RGD:6480464 |
G |
Hsd11b1 |
hydroxysteroid 11-beta dehydrogenase 1 |
|
13 |
111,946,626 |
111,996,536 |
RGD:6480464 |
G |
Huwe1 |
HECT, UBA and WWE domain containing E3 ubiquitin protein ligase 1 |
|
X |
21,474,627 |
21,603,348 |
RGD:6480464 |
G |
Mapk1 |
mitogen activated protein kinase 1 |
|
11 |
88,203,863 |
88,273,301 |
RGD:6480464 |
G |
Mapk3 |
mitogen activated protein kinase 3 |
|
1 |
198,192,773 |
198,198,975 |
RGD:6480464 |
G |
Mcl1 |
MCL1 apoptosis regulator, BCL2 family member |
|
2 |
197,786,212 |
197,788,992 |
RGD:6480464 |
G |
Nos2 |
nitric oxide synthase 2 |
|
10 |
66,188,290 |
66,221,621 |
RGD:6480464 |
G |
Nos3 |
nitric oxide synthase 3 |
|
4 |
7,321,908 |
7,342,404 |
RGD:6480464 |
G |
Parp1 |
poly (ADP-ribose) polymerase 1 |
|
13 |
98,857,255 |
98,889,444 |
RGD:6480464 |
G |
Slc10a1 |
solute carrier family 10 member 1 |
|
6 |
104,617,730 |
104,631,355 |
RGD:6480464 |
|
G |
Abcb11 |
ATP binding cassette subfamily B member 11 |
|
3 |
55,480,024 |
55,587,946 |
RGD:6480464 |
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
|
10 |
549,537 |
672,235 |
RGD:6480464 |
G |
Il10 |
interleukin 10 |
|
13 |
47,738,933 |
47,743,392 |
RGD:6480464 |
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
|
7 |
30,003,429 |
30,162,095 |
RGD:6480464 |
G |
Por |
cytochrome p450 oxidoreductase |
|
12 |
23,998,411 |
24,017,063 |
RGD:6480464 |
G |
Sod2 |
superoxide dismutase 2 |
|
1 |
47,914,757 |
47,921,587 |
RGD:6480464 |
Term paths to the root
|